All In Biotech

Drug Trial Radar · NCT02400476

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide

Last checked: Nov 19, 2026Latest source record: May 6, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

563

Actual

Start

Feb 2015

Primary completion

Apr 22, 2021

Study completion Apr 22, 2021

Sponsor

Lead sponsor
Puma Biotechnology, Inc.Industry
Sponsor type
Industry
First posted
Mar 27, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide or other prophylactic measures.

Conditions

  • Early Stage HER2+ Breast Cancer

Interventions

  • NeratinibDrug

  • LoperamideDrug

  • ColestipolDrug

    2 g twice daily with or without food for one 28 day cycle

  • BudesonideDrug

    9 mg extended release tablets once daily with or without food for 28 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Patients With Grade 3 or Higher Diarrhea, According to NCI CTCAE v4.0.Time frame: From first dose of investigational product through 28 days after last dose, up to 15.5 months.

Locations

58 sites in 7 countries. Site status is shown where the registry gives one.

  • Alabama Oncology

    Birmingham, Alabama

  • Compassionate Care Research Group Inc.

    Corona, California

  • St. Joseph Heritage Healthcare

    Fullerton, California

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

  • Emad Ibrahim, M.D., Inc.

    Redlands, California

  • Torrance Memorial Physician Network Cancer Care Associates

    Redondo Beach, California

  • Compassionate Care Research Group Inc.

    Riverside, California

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California

  • The Oncology Institute of Hope and Innovation

    Santa Ana, California

  • Cancer Center of Santa Barbara with Sansum Clinic

    Santa Barbara, California

  • Central Coast Medical Oncology Corporation

    Santa Maria, California

  • Memorial Healthcare System

    Hollywood, Florida

  • Florida Cancer Research Institute, LLC

    Plantation, Florida

  • Hematology-Oncology Associates of the Treasure Coast

    Port Saint Lucie, Florida

  • Baptist Health Urgent Care Sawgrass

    Sunrise, Florida

  • Cancer Treatment Centers of America

    Newnan, Georgia

  • Decatur Memorial Hospital Cancer Care Specialists of Central Illinois

    Decatur, Illinois

  • Ingalls Memorial Hospital

    Harvey, Illinois

  • Norton Cancer Institute

    Louisville, Kentucky

  • Central Maine Medical Center

    Lewiston, Maine

  • University of Maryland, Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

  • North Mississippi Medical Center Hematology and Oncology Services

    Tupelo, Mississippi

  • Washington University School of Medicine

    St Louis, Missouri

  • Great Plains Health (Callahan Cancer Center)

    North Platte, Nebraska

  • Saint Barnabas Medical Center

    Livingston, New Jersey

  • Jersey Shore University Medical Center

    Neptune City, New Jersey

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey

  • MD Anderson Cancer Center at Cooper

    Voorhees Township, New Jersey

  • Clinical Research Alliance, Inc

    Lake Success, New York

  • Good Samaritan Hospital Samaritan Pastega Regional Cancer Center

    Corvallis, Oregon

  • Providence Portland Medical Center

    Portland, Oregon

  • Magee-Womens Hospital of UPMC

    Pittsburgh, Pennsylvania

  • Charleston Hematology Oncology Associates

    Charleston, South Carolina

  • Saint Joseph / Candler SC Cancer Specialists

    Hilton Head Island, South Carolina

  • Coastal Bend Cancer Center

    Corpus Christi, Texas

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas

  • Community Cancer Trials of Utah

    Ogden, Utah

  • Utah Cancer Specialists

    Salt Lake City, Utah

  • Inova Schar Cancer Institute

    Fairfax, Virginia

  • Sydney Adventist Hospital

    Wahroonga, New South Wales, Australia

Showing 40 of 58 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.